SB22-027
Prescription Drug Monitoring Program
Concerning changes to the prescription drug monitoring program pursuant to the March 2021 audit report issued by the office of the state auditor.
Session:
2022 Regular Session
Subject:
Bill Summary
Health Care & Health Insurance
The act clarifies that:
- Each prescriber of prescription drugs must register and maintain a user account with the prescription drug monitoring program (program); and
- Each licensed health-care practitioner must query the program prior to filling a prescription for every opioid or benzodiazepine.
The act requires the group tasked with developing a strategic plan to reduce prescription drug misuse to evaluate and make recommendations to the executive director of the department of regulatory agencies regarding balancing the use of the program as a health-care tool with enforcement of the requirements of the program.
(Note: This summary applies to this bill as enacted.)